Clinical Trials
38 trialsB7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
St. Jude Children's Research Hospital
COCORIVO
Centre Henri Becquerel
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer
Roswell Park Cancer Institute
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
BladMetrix
Oslo University Hospital
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Jinling Hospital, China
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Seattle Children's Hospital
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
Duke University
Skippy 1
Leiden University Medical Center
Ivonescimab in the Treatment of Multiple Advanced Tumors
Fudan University
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Children's National Research Institute
Pemigatinib and Immune Checkpoint Inhibitor Treated FGFR1/2/3 Alteration Advanced Solid Tumor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
BANN
University Medical Center Groningen
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
Steba Biotech S.A.
MRI
University of Chicago
ART-02
Charite University, Berlin, Germany
Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors
Sichuan University
CUDI-RCC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
ChemoRenCan
University Hospital, Bordeaux
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute
PCM301
Steba Biotech S.A.
MAJA
Spanish Oncology Genito-Urinary Group
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Cedars-Sinai Medical Center
Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer
University of Chicago
Study of WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
PCM304
Steba Biotech S.A.
B-Receptor Signaling in Cardiomyopathy
Stanford University
REMISCAN
Assistance Publique - Hôpitaux de Paris
Randomized Phase 2 Trial of Pre-chemotherapy Leukine vs. Leukine-Dexamethasone in Combination With Gemzar & 5-FU in Patients With Metastatic Renal Cell Carcinoma
University of Kentucky
Study Using WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
University of Michigan Rogel Cancer Center
A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma
Corewell Health East
Radiotherapy vs Observation for CRPC
Zhengzhou University
SMAT
Association of Urologic Oncology (AUO)
Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
LanZhou University